[1] 黄翔翔, 谭婷, 禹利君, 等. 茯砖茶对葡聚糖硫酸钠诱导UC小鼠炎症及肠道微生物的影响[J]. 茶叶科学, 2021, 41(5): 681-694. Huang X X, Tan T, Yu L J, et al.Effects of Fu brick tea on inflammation and intestinal microflora diversity in mice with DSS-induced ulcerative colitis[J]. Journal of Tea Science, 2021, 41(5): 681-694. [2] Wang C P J, Byun M J, Kim SN, et al. Biomaterials as therapeutic drug carriers for inflammatory bowel disease treatment[J]. Journal of Controlled Release, 2022, 345: 1-19. doi: 10.1016/j.jconrel.2022.02.028. [3] Sun W, Li Z B, Zhang X H, et al.Biomaterial-based therapeutic strategies for inflammatory bowel disease[J]. Biomaterials, 2026, 324: 123462. doi: 10.1016/j.biomaterials.2025.123462. [4] 胡安恺, 姚立筠, 赵悦伶, 等. 茯砖茶提取物对葡聚糖硫酸钠诱导小鼠炎症性肠病的保护作用研究[J]. 茶叶科学, 2019, 39(6): 641-651. Hu A K, Yao L Y, Zhao Y L, et al.Protective effects of fu brick tea extracts on inflammatory bowel disease induced by dextran sulfate sodium in mice[J]. Journal of Tea Science, 2019, 39(6): 641-651. [5] Liu D D, Saikam V, Skrada K A, et al.Inflammatory bowel disease biomarkers[J]. Medicinal Research Reviews, 2022, 42(5): 1856-1887. [6] Singh S.Positioning therapies for the management of inflammatory bowel disease[J]. Nature Reviews Gastroenterology & Hepatology, 2023, 20(7): 411-412. [7] Luo H, Cao G Q, Luo C, et al.Emerging pharmacotherapy for inflammatory bowel diseases[J]. Pharmacological Research, 2022, 178: 106146. doi: 10.1016/j.phrs.2022.106146. [8] Takahashi Y, Takakura Y.Extracellular vesicle-based therapeutics: extracellular vesicles as therapeutic targets and agents[J]. Pharmacology & Therapeutics, 2023, 242: 108352. doi: 10.1016/j.pharmthera.2023.108352. [9] Mondal J, Pillarisetti S, Junnuthula V, et al.Hybrid exosomes, exosome-like nanovesicles and engineered exosomes for therapeutic applications[J]. Journal of Controlled Release, 2023, 353: 1127-1149. doi: 10.1016/j.jconrel.2022.12.027. [10] Yang L T, Zhang D Z, Lu D L, et al.Plant-Derived Exosome-like nanovesicles-created injectable hydrogel for augmented cancer immunotherapy[J]. Chemical Engineering Journal, 2024, 491: 152032. doi: 10.1016/j.cej.2024.152032. [11] Li D, Cao G F, Yao X L, et al.Tartary buckwheat-derived exosome-like nanovesicles against starch digestion andtheir interaction mechanism[J]. Food Hydrocolloids, 2023, 141: 108739. doi: 10.1016/j.foodhyd.2023.108739. [12] 孙若璠, 高健健, 周丹阳, 等. 基于代谢组学的不同贮藏年份紧压寿眉白茶化学成分分析[J]. 食品科学, 2025, 46(7): 217-228. Sun R P, Gao J J, Zhou D Y, et al.Metabolomics analysis of chemical constituents in compressed shoumei white tea with different storage periods[J]. Food Science, 2025, 46(7): 217-228. [13] Zu M, Xie D, Canup B S B, et al. ‘Green’ nanotherapeutics from tea leaves for orally targeted prevention and alleviation of colon diseases[J]. Biomaterials, 2021, 279: 121178. doi: 10.1016/j.biomaterials.2021.121178. [14] 肖佳豪, 张群, 潘兆平, 等. 低温超微粉碎对茶枝柑果肉粉理化性质和功能特性的影响[J]. 食品科学, 2024, 45(20): 220-231. Xiao J H, Zhang Q, Pan Z P, et al.Effect of low-temperature superfine grinding on the physicochemical and functional properties of the pulp powder of citrus reticulata ‘Chachi’[J]. Food Science, 2024, 45(20): 220-231. [15] 周闯, 赵燕妮, 周梦雪, 等. 基于代谢组学的‘铁观音’和‘水仙’品种茶叶化学成分解析[J]. 食品科学, 2024, 45(4): 171-182. Zhou C, Zhao Y N, Zhou M X, et al.Metabolomic analysis of the chemical composition of ‘Tieguanyin’ and ‘Shuixian’ tea[J]. Food Science, 2024, 45(4): 171-182. [16] Zhou M, Wang J, Pan J, et al.Nanovesicles loaded with a TGF-β receptor 1 inhibitor overcome immune resistance to potentiate cancer immunotherapy[J]. Nature Communications, 2023, 14(1): 3593. doi: 10.1038/s41467-023-39035-x. [17] Rome S.Biological properties of plant-derived extracellular vesicles[J]. Food Function, 2019, 10(2): 529-538. [18] Reker D, Blum S M, Steiger C, et al. “Inactive” ingredients in oral medications [J]. Science Translational Medicine, 2019, 11(483): eaau6753. doi: 10.1126/scitranslmed.aau6753. [19] Fadok V A, Voelker D R, Campbell P A, et al.Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages[J]. Journal of Immunology, 1992, 148(7): 2207-2216. [20] Di Gioia S, Hossain M N, Conese M.Biological properties and therapeutic effects of plant-derived nanovesicles[J]. Open Medicine, 2020, 15(1): 1096-1122. [21] Sung J, Alghoul Z, Long D, et al.Oral delivery of IL-22 mRNA-loaded lipid nanoparticles targeting the injured intestinal mucosa: a novel therapeutic solution to treat ulcerative colitis[J]. Biomaterials, 2022, 288: 121707. doi: 10.1016/j.biomaterials.2022.121707. [22] Teslaa T, Bartman C R, Jankowski C S R, et al. The source of glycolytic intermediates in mammalian tissues[J]. Cell Metabolism, 2021, 33(2): 367-378. [23] Anjum J, Mitra S, Das R, et al.A renewed concept on the MAPK signaling pathway in cancers: polyphenols as a choice of therapeutics[J]. Pharmacological Research, 2022, 184: 106398. doi: 10.1016/j.phrs.2022.106398. [24] Shah K, Al-Haidari A, Sun J, et al.T cell receptor (TCR) signaling in health and disease[J]. Signal Transduction and Targeted Therapy, 2021, 6(1): 412. doi: 10.1038/s41392-021-00823-w. [25] Wen P, Sun Z, Gou F, et al.Oxidative stress and mitochondrial impairment: key drivers in neurodegenerative disorders[J]. Ageing Research Reviews, 2025, 104: 102667. doi: 10.1016/j.arr.2025.102667. [26] Min D K, Kim Y E, Kim M K, et al.Orally Administrated inflamed colon-targeted nanotherapeutics for inflammatory bowel disease treatment by oxidative stress level modulation in colitis[J]. ACS Nano, 2023, 17(23): 24404-24416. [27] Yang H, Zhu C, Yuan W, et al.Mannose-rich oligosaccharides-functionalized selenium nanoparticles mediates Macrophage reprogramming and inflammation resolution in ulcerative colitis[J]. Chemical Engineering Journal, 2022, 435: 131715. doi: 10.1016/j.cej.2021.131715. [28] Zhang T, Xu R, Zhao N, et al.Rational design of lycopene emulsion-based nanofood for Lactobacillus plantarum to enhance the growth and flavor production[J]. Food Hydrocolloids, 2022, 127: 107518. doi:10.1016/j.foodhyd.2022.107518. [29] Yan K, Li M J, Huang J P, et al.Development and stability assessment of Arachidonic acid nanoemulsions stabilized by sodium caseinate-gum arabic complexes[J]. LWT, 2025, 229: 118170. doi: 10.1016/j.lwt.2025.118170. [30] Li M, Dia V P, Wu T.Ice recrystallization inhibition effect of cellulose nanocrystals: influence of sucrose concentration[J]. Food Hydrocolloids, 2021, 121: 107011. doi: 10.1016/j.foodhyd.2021.107011. [31] Yang M, Liu J B, Liu C M, et al.Programmable food-derived peptide coassembly strategies for boosting targeted colitis therapy by enhancing oral bioavailability and restoring gut microenvironment homeostasis[J]. ACS Nano, 2025, 19(1): 600-620. [32] Zhang H J, Deng A J, Zhang Z H, et al.The protective effect of epicatechin on experimental ulcerative colitis in mice is mediated by increasing antioxidation and by the inhibition of NF-κB pathway[J]. Pharmacological Reports, 2016, 68(3): 514-520. [33] Wu Z H, Huang S M, Li T T, et al.Gut microbiota from green tea polyphenol-dosed mice improves intestinal epithelial homeostasis and ameliorates experimental colitis[J]. Microbiome, 2021, 9(1): 1-22 [34] Nishi K, Nakatani Y, Ishida M, et al.Anti-inflammatory activity of the combination of nobiletin and docosahexaenoic acid in lipopolysaccharide-stimulated RAW 264.7 cells: a potential synergistic anti-inflammatory effect[J]. Nutrients, 2024, 16(13): 2080. doi: 10.3390/nu16132080. [35] Kovács T, Varga G, Érdes D, et al.Dietary phosphatidylcholine supplementation attenuates inflammatory mucosal damage in a rat model of experimental colitis[J]. Shock, 2012, 38(2): 177-185. |